Balazuc, A M <br/><br/>
In vivo efficiency of targeted norfloxacin against persistent, isoniazid-insensitive, Mycobacterium bovis BCG present in the physiologically hypoxic mouse liver.  [electronic resource] 

 -  Microbes and infection  Jun 2005 
 - 969-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1286-4579 
<br/><br/><label>Standard No.: </label>10.1016/j.micinf.2005.03.037  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antitubercular Agents--administration & dosage<br/>Drug Design<br/>Drug Resistance, Bacterial<br/>Female<br/>Hypoxia--physiopathology<br/>Isoniazid--pharmacology<br/>Liver--microbiology<br/>Mice<br/>Mice, Inbred C57BL<br/>Molecular Structure<br/>Mycobacterium bovis--drug effects<br/>Norfloxacin--administration & dosage<br/>Prodrugs<br/>Spleen--microbiology